Charles River Laboratories International Balance Sheet Health
Financial Health criteria checks 4/6
Charles River Laboratories International has a total shareholder equity of $3.7B and total debt of $2.6B, which brings its debt-to-equity ratio to 71.1%. Its total assets and total liabilities are $8.2B and $4.4B respectively. Charles River Laboratories International's EBIT is $627.2M making its interest coverage ratio 4.8. It has cash and short-term investments of $327.0M.
Key information
71.1%
Debt to equity ratio
US$2.63b
Debt
Interest coverage ratio | 4.8x |
Cash | US$327.04m |
Equity | US$3.70b |
Total liabilities | US$4.45b |
Total assets | US$8.15b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CRL *'s short term assets ($1.7B) exceed its short term liabilities ($954.8M).
Long Term Liabilities: CRL *'s short term assets ($1.7B) do not cover its long term liabilities ($3.5B).
Debt to Equity History and Analysis
Debt Level: CRL *'s net debt to equity ratio (62.3%) is considered high.
Reducing Debt: CRL *'s debt to equity ratio has reduced from 108.5% to 71.1% over the past 5 years.
Debt Coverage: CRL *'s debt is well covered by operating cash flow (26.8%).
Interest Coverage: CRL *'s interest payments on its debt are well covered by EBIT (4.8x coverage).